Adjunct Professor Chorbanov: Vaccine efficacy is in doubt – ᐉ News from Bulgaria • latest news and current information



[ad_1]

Vaccines against COVID-19 must be approached rationally, not emotionally. This was stated in “Face to Face” on bTV by BAS immunologist Assoc. Prof. Andrey Chorbanov. He noted that the spread of COVID-19 will be naturally limited, but with immunizations this process will be faster.

“In a large percentage of people, the virus will not be detected because they have very good immune defenses. Between 38 and 50% of people have extremely high levels of T-cell protection. This means that these people will never contract the virus, “said the immunologist.

Adjunct Professor Chorbanov explained that antibodies in cured patients often have a negative effect. He noted that very few hospitals around the world are treated with blood plasma. “It is believed that antibodies can be a conduit for the virus and enter cells that should not.” The immunity of T cells is what protects us, “explained the expert.

The immunologist said that if the vaccine was good, it would create the T-cell immunity in question. He noted that he strongly supports vaccine prophylaxis.


“If the vaccines approved by the EC are good, we do not know. And we do not know because of the way the clinical trials were carried out. This is unprecedented in methodology, I am concerned about the short timeframes in which the trials were carried out. The scientific community is concerned that there is no scientific data on these vaccines. The results are confirmed in protocols. The problem is the choice of test groups: “Modern”, “Pfizer”, “AstraZeneca”, none of them it tests the vaccine in the target groups that are most vulnerable to the virus: pregnant women, children, the elderly. The groups are mostly young and healthy people, “he added.

Adjunct Professor Chorbanov added that there can be no bad test results of the preparations when applied to this group of people. According to him, this questions the effectiveness of vaccines.

“Young, healthy people rarely die from the virus. They generally have a terribly high viral load from repeated encounters with the virus or have genetic predispositions. Between 3 and 5% of the world’s population does not respond to it. vaccines or infections, they do not have lasting immunity. That is why there are reinfected people, “explained the immunologist, adding that the Ebola vaccine was launched after 5 years of testing.

He commented that currently tested drugs have acceptable side effects, but the question is whether others will appear when applied to risk groups.

According to him, even he is afraid of the virus and it is not reasonable to deny its existence. Adjunct Professor Chorbanov admitted that even if you keep your distance, wear a mask, and disinfect yourself frequently, this doesn’t 100% prevent you from encountering the virus. According to him, there is scientific evidence of a link between stress and the body’s immune response.

“Panic has an extremely severe effect on the immune system. We are all positive for the herpes virus, in some people it never appears, in others it appears every week. It kills under severe stress,” explained the immunologist, adding that Immunostimulants should not be exaggerated because there may be a negative reaction in the body.



[ad_2]